Coronary Model Shows Limits in Cath-Referred Patients - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Coronary Model Shows Limits in Cath-Referred Patients

An interpretable machine-learning model classified angiographic coronary artery disease in patients referred for coronary angiography, but high disease prevalence and unclear inflammatory signals limited clinical interpretation.

  • By

  • Andrea Surnit

  • June 22, 2026

  • 5 min

Share

Clinical Scorecard: Coronary Model Shows Limits in Cath-Referred Patients

At a Glance

CategoryDetail
ConditionCoronary Artery Disease (CAD)
Key MechanismsMachine-learning model incorporating cardiovascular risk factors and inflammatory biomarkers.
Target PopulationPatients referred for coronary angiography without acute myocardial infarction.
Care SettingRetrospective single-center study.

Key Highlights

  • Study included 3,482 patients with suspected CAD.
  • Final model achieved 81% accuracy and 82% sensitivity.
  • Hypertension, hyperlipidemia, sex, diabetes, and triglyceride levels were key predictors.
  • Model not validated in independent external cohort.
  • Study did not assess medication use directly.

Guideline-Based Recommendations

Diagnosis

  • CAD defined as at least 50% stenosis in at least one major coronary artery.

Management

  • Model should be interpreted as a classifier of angiographic stenosis.

Monitoring & Follow-up

  • Further validation needed to determine clinical utility.

Risks

  • Model performance not established in lower-prevalence outpatient or primary care populations.

Patient & Prescribing Data

Patients undergoing coronary angiography for suspected CAD.

Prior treatment, particularly statin therapy, may affect inflammatory biomarker levels.

Clinical Best Practices

  • Consider class imbalance when interpreting model performance metrics.
  • Use multiple modalities for comprehensive assessment of CAD.

Related Resources & Content

Original Source(s)

Coronary Model Shows Limits in Cath-Referred Patients

  • by Andrea Surnit

  • June 22, 2026

Related Content

TOFA may drive weight loss without reducing food intake

The oral compound increased energy expenditure, reduced fat mass, and improved metabolic measures in male mouse models.

Roxadustat Treatment After PCI Among Patients With ST-Segment Elevation Myocardial Infarction: A Randomized

Female patients less likely to receive invasive care

Review identifies recurring sex-based differences across specialties, including lower use of intensive and guideline-compliant treatment among female patients.